FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224862014> ?p ?o ?g. }

• W4224862014 endingPage "366" @default.
• W4224862014 startingPage "351" @default.
• W4224862014 abstract "COVID-19, a severe acute respiratory syndrome caused by SARS-CoV-2, may predispose to thrombotic events, especially when combined with antiphospholipid antibodies (aPL). However, there are limited data on prevalence and antigenic specificity of aPL in COVID-19. Complement activation is assumed to play an important role in pathogenesis of COVID-19-associated coagulopathy. During the SARS-CoV-2 pandemic, it is necessary to identify important biomarkers for predicting severe course of COVID-19 and risk of thrombotic complications. Our objective was to evaluate the aPL profile, quantitative content and activity of complement and its components in COVID-19 patients graded by severity in the course of time. IgM and IgG antibodies to cardiolipin (CL), phosphatidylserine (PS), β2-glycoprotein-I (β2-GP-I), prothrombin (PT), annexin V (An V), as well as C1q complement component, content of its C3 and C4 components and total complement activity were determined in blood serum using ELISA approach. 141 patients with COVID-19 were included in the study. Group 1 consisted of 39 patients with mild form, group 2 (65 patients) presented with moderate form, and group 3 included 37 patients with severe form of COVID-19. Blood samples were obtained on day 3-7 of the disease (1st point) and after 14-28 days (2nd point). The results were as follows: aPL were detected in 29.1% of the total COVID-19 cohort, frequency of aPL detection by the severity grade did not differ (33.3%, 24.6% and 32.4%). In 8.5% of the patients, aPL were detected only at the 1st time point; in 14.2%, only at the 2nd point; and in 6.4% of the cases, at the both time points. Antibodies to PT (16.3%) and An V (11.3%) were revealed more frequently. The detection frequency of antibodies to PT was significantly higher than antibodies to CL and PS (7.1%), β2-GP-I (7.8%). The prevalence of aPL in groups 1 and 3 did not differ. At the 1st point in group 3, increased levels of C4 (89.2%) and C3 (24.3%) in blood, and a decrease in complement activity (35.1%) were more often observed than in group 1. At the 2nd time point in group 3, a decrease in complement activity was often detected (59.5%). The C3 levels exceeding 720 μg/ml were found to predict a 2.6-fold increased risk of severe COVID-19, and this risk became 3.3 times higher at C4 levels of > 740 μg/ml. The antibodies to PT and An V are often detected in COVID-19 patients, along with low prevalence of antibodies to CL and β2-GP-I. These antibodies can be involved in pathogenesis of COVID-19-associated coagulopathy, being detectable at the late stage of the disease, and they may trigger APS in predisposed patients and reconvalescents. Although presence of aPL antibodies is not associated with COVID-19 severity, their persistence over the period of convalescence may be an additional risk factor for thromboembolic complications. The COVID-19 patients are characterized by activation of the complement system, which increases in severe cases, and manifests with increased or decreased levels of C3 complement component, increased levels of C4 component in blood, and a decreased total complement activity. Quantitative determination of C3 and C4 complement components over the period of COVID-19 progression is of prognostic value, with respect to severity of the disease." @default.
• W4224862014 created "2022-04-27" @default.
• W4224862014 creator A5014900906 @default.
• W4224862014 creator A5025540852 @default.
• W4224862014 creator A5027528661 @default.
• W4224862014 creator A5050731396 @default.
• W4224862014 creator A5088977488 @default.
• W4224862014 creator A5089391816 @default.
• W4224862014 date "2022-04-20" @default.
• W4224862014 modified "2023-10-01" @default.
• W4224862014 title "Profile of antiphospholipid antibodies and complement system in COVID-19 patients of different severity" @default.
• W4224862014 cites W1486365785 @default.
• W4224862014 cites W1521036527 @default.
• W4224862014 cites W1563349777 @default.
• W4224862014 cites W1970232820 @default.
• W4224862014 cites W2037466316 @default.
• W4224862014 cites W2070909340 @default.
• W4224862014 cites W2252943105 @default.
• W4224862014 cites W2322550083 @default.
• W4224862014 cites W2574087492 @default.
• W4224862014 cites W2789927285 @default.
• W4224862014 cites W2898080189 @default.
• W4224862014 cites W2938600841 @default.
• W4224862014 cites W2964012416 @default.
• W4224862014 cites W2965276188 @default.
• W4224862014 cites W3001638293 @default.
• W4224862014 cites W3008196127 @default.
• W4224862014 cites W3014573995 @default.
• W4224862014 cites W3016123694 @default.
• W4224862014 cites W3019130299 @default.
• W4224862014 cites W3020301027 @default.
• W4224862014 cites W3024075213 @default.
• W4224862014 cites W3025680240 @default.
• W4224862014 cites W3036101703 @default.
• W4224862014 cites W3039804972 @default.
• W4224862014 cites W3045035401 @default.
• W4224862014 cites W3089333716 @default.
• W4224862014 cites W3093252727 @default.
• W4224862014 cites W3094906854 @default.
• W4224862014 cites W3096640075 @default.
• W4224862014 cites W3118686452 @default.
• W4224862014 cites W3122296162 @default.
• W4224862014 cites W3158942134 @default.
• W4224862014 cites W4206003379 @default.
• W4224862014 cites W4239160933 @default.
• W4224862014 doi "https://doi.org/10.15789/1563-0625-poa-2465" @default.
• W4224862014 hasPublicationYear "2022" @default.
• W4224862014 type Work @default.
• W4224862014 citedByCount "1" @default.
• W4224862014 countsByYear W42248620142022 @default.
• W4224862014 crossrefType "journal-article" @default.
• W4224862014 hasAuthorship W4224862014A5014900906 @default.
• W4224862014 hasAuthorship W4224862014A5025540852 @default.
• W4224862014 hasAuthorship W4224862014A5027528661 @default.
• W4224862014 hasAuthorship W4224862014A5050731396 @default.
• W4224862014 hasAuthorship W4224862014A5088977488 @default.
• W4224862014 hasAuthorship W4224862014A5089391816 @default.
• W4224862014 hasBestOaLocation W42248620141 @default.
• W4224862014 hasConcept C111684460 @default.
• W4224862014 hasConcept C126322002 @default.
• W4224862014 hasConcept C159654299 @default.
• W4224862014 hasConcept C203014093 @default.
• W4224862014 hasConcept C2776874634 @default.
• W4224862014 hasConcept C2779134260 @default.
• W4224862014 hasConcept C2779936836 @default.
• W4224862014 hasConcept C2780942790 @default.
• W4224862014 hasConcept C3008058167 @default.
• W4224862014 hasConcept C524204448 @default.
• W4224862014 hasConcept C71924100 @default.
• W4224862014 hasConcept C90924648 @default.
• W4224862014 hasConceptScore W4224862014C111684460 @default.
• W4224862014 hasConceptScore W4224862014C126322002 @default.
• W4224862014 hasConceptScore W4224862014C159654299 @default.
• W4224862014 hasConceptScore W4224862014C203014093 @default.
• W4224862014 hasConceptScore W4224862014C2776874634 @default.
• W4224862014 hasConceptScore W4224862014C2779134260 @default.
• W4224862014 hasConceptScore W4224862014C2779936836 @default.
• W4224862014 hasConceptScore W4224862014C2780942790 @default.
• W4224862014 hasConceptScore W4224862014C3008058167 @default.
• W4224862014 hasConceptScore W4224862014C524204448 @default.
• W4224862014 hasConceptScore W4224862014C71924100 @default.
• W4224862014 hasConceptScore W4224862014C90924648 @default.
• W4224862014 hasIssue "2" @default.
• W4224862014 hasLocation W42248620141 @default.
• W4224862014 hasOpenAccess W4224862014 @default.
• W4224862014 hasPrimaryLocation W42248620141 @default.
• W4224862014 hasRelatedWork W1972654344 @default.
• W4224862014 hasRelatedWork W2146927838 @default.
• W4224862014 hasRelatedWork W2357922212 @default.
• W4224862014 hasRelatedWork W2383612831 @default.
• W4224862014 hasRelatedWork W2414645603 @default.
• W4224862014 hasRelatedWork W3029329823 @default.
• W4224862014 hasRelatedWork W3029466353 @default.
• W4224862014 hasRelatedWork W3032540778 @default.
• W4224862014 hasRelatedWork W3048583408 @default.
• W4224862014 hasRelatedWork W4366303857 @default.
• W4224862014 hasVolume "24" @default.
• W4224862014 isParatext "false" @default.

• next